6Roodman GD, Mechanisms of bone metastasis [ J ]. N Engl J Med,2004,350(16) :1655 - 1664.
7Diel IJ, Solomayer EF, Costa SD, et al. Reduction in new metastases in breast cancer with adjuvant clodronate treatment [J]. N Engl J Med,1998,339(6) :357 -363.
8Michaelson MD, Smith MR. Bisphosphonates for treatment and prevention of bone metastases [ J]. J Clin Oncol, 2005,23 ( 32 ) : 8219 - 8224.
9Hirbe AC, Rubin J, Ulu kan O, et al. Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone [ J ]. Proc Natl Acad Sci U S A, 2007,104 (35) : 14062 - 14067.
10Daubin F, Le Gall C, Gasser J, et al. Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis [ J ]. J Natl Cancer Inst, 2007,99 (4) : 322 - 330.
二级参考文献23
1Taichman RS, Cooper C, Keller ET, et al. Use of the stromal cell- derive factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res,2002,62 : 1832-1837.
2Shim H, Lau SK, Devi S, et al. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1 alpha. Biochem Biophys Res Commun,2006,346:252-258.
3Zhang L,Yeger H, Das B,et al. Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma. Neoplasia,2007 ,9 :3646.
4Chinni SR,Sivalogan S,Dong Z,et al. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone mieroenvironment-assoeiated CXCL12. Prostate, 2006,66:32-48.
5Nakashima T, Okuda K, Kojiro M,et al. Pathology of hepatocellular carcinoma in japan.232 Consecutive cases autopsied in ten years.Cancer,1983,51:863-877.
6Asahara T, Dohi K, Hino H, et al. A case of HCC with bone metastasis respondin g to radiotherapy after successful hepatectomy of primary lesion.Hiroshima J Med Sci,1999,48:35-39.
7Healey JH, Brown HK. Complications of bone metastases.Cancer,2000,88 Suppl 12 :2940-2951.
8Imamura H, Masutani S, Tatsuta M,et al. A case report of successful transcatheter arterial embolization therapy for osseous metastasis of HCC.Gan To Kagaku R yoho,2000,27:1941-1946.
9Seratini AN. Therapy of metastatic bonepain.J Nucl Med,2001,42:895-906.
10Ratanatharathorn V, Powers WE, Moss WT, et al. Bone metastasis:review and critical analysis random allocation trials of local field treatment.Int J Radiat Oncol Biol Phys,1999,44:1-8.
